Across TCGA pan-cancer cohorts, PRSS54 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of PRSS54’s most consistent transcriptional readouts.
The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where PRSS54 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types PRSS54 is over-expressed in tumor.
KIRP and CHOL are the cancer types where PRSS54 tumor–normal differential expression is most reproducible.